Nal-Iri and 5-FU/LV Compared to 5-FU/LV in Patients with Cholangio- and Gallbladder Carcinoma Previously Treated with Gemcitabine-Based Therapies: The AIO NALIRICC TrialArndt Vogel, Martha M. Kirstein, Patrick Wenzel et al.|SSRN Electronic Journal|2024Cited by 0